←Back to Expert Scholars
Translational Medicine / 转化医学Squamous NSCLC Advances
Paul Baas
MD, PhD
🏢Netherlands Cancer Institute🌐Netherlands
Professor of Thoracic Oncology
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Paul Baas led CheckMate-743 establishing dual immunotherapy in mesothelioma and contributed to squamous NSCLC trials. His work has advanced IO-based therapy in thoracic malignancies. He remains a senior European trialist in thoracic oncology.
Share:
🧪Research Fields 研究领域
Mesothelioma
Squamous NSCLC
Immunotherapy
CheckMate trials
European trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Paul Baas 的研究动态
Follow Paul Baas's research updates
留下邮箱，当我们发布与 Paul Baas（Netherlands Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment